The DOI matches its Crossref record; 224 of the 224 references it cites were found in a registry or an index.
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Open accessAbstract
Platinum-based anticancer drugs, including cisplatin, carboplatin, oxaliplatin, nedaplatin, and lobaplatin, are heavily applied in chemotherapy regimens. However, the intrinsic or acquired resistance severely limit the clinical application of platinum-based treatment. The underlying mechanisms are incredibly complicated. Multiple transporters participate in the active transport of platinum-based antitumor agents, and the altered expression level, localization, or activity may severely decrease the cellular platinum accumulation. Detoxification components, which are commonly increasing in resistant tumor cells, can efficiently bind to platinum agents and prevent the formation of platinum-DNA adducts, but the adducts production is the determinant step for the cytotoxicity of platinum-based antitumor agents. Even if adequate adducts have formed, tumor cells still manage to survive through increased DNA repair processes or elevated apoptosis threshold. In addition, autophagy has a profound influence on platinum resistance. This review summarizes the critical participators of platinum resistance mechanisms mentioned above and highlights the most potential therapeutic targets or predicted markers. With a deeper understanding of the underlying resistance mechanisms, new solutions would be produced to extend the clinical application of platinum-based antitumor agents largely.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–224 of 224
Zheng, D., Wu, W., Dong, N., Jiang, X., Xu, J., Zhan, X., Zhang, Z., & Hu, Z. (2017) · Molecular Carcinogenesis · doi:10.1002/mc.22676 · Cited by 32
Competitive reactions among glutathione, cisplatin and copper-phenanthroline complexes
Cadoni, E., Valletta, E., Caddeo, G., Isaia, F., Cabiddu, M. G., Vascellari, S., & Pivetta, T. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.05.004 · Cited by 31
MicroRNA-195 acts as an anti-proliferative miRNA in human melanoma cells by targeting Prohibitin 1
Cirilo, P. D. R., Andrade, L. N. D. S., Corrêa, B. R. S., Qiao, M., Furuya, T. K., Chammas, R. J., & Penalva, L. O. F. (2017) · BMC Cancer · doi:10.1186/s12885-017-3721-7 · Cited by 31
Ma, L., Xu, Y., Su, J., Yu, H., KANG, J., Li, H., Li, X., Xie, Q., Yu, C., Sun, L., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3176 · Cited by 30
Ushijima, R., Takayama, K., Izumi, M., Harada, T., Horiuchi, Y., Uchino, J., Hara, N., & Nakanishi, Y. (2007) · PubMed · Cited by 30
Liu, Y., Chang, P., & Chao, C. C. ‐. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv934 · Cited by 28
Yamamoto, M., Tsujinaka, T., Shiozaki, H., Doki, Y., Tamura, S., Inoue, M., Hirao, M., & Monden, M. (1999) · Oncology · doi:10.1159/000011988 · Cited by 27
BRCA Mutation and Its Association With Colorectal Cancer
Soyano, A. E., Baldeo, C., & Kasi, P. M. (2018) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2018.06.006 · Cited by 27
miR-148a increases the sensitivity to cisplatin by targeting Rab14 in renal cancer cells
Kim, E., Kim, T. G., Sung, E., Song, I., Kim, J., Doh, K., & Lee, T. J. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3851 · Cited by 26
Peng, P., Lv, B., Wang, Z., Liao, H., Liu, Y., Zhong, L., Con, Y.-Y., & Huang, P. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834016675099 · Cited by 25
Lehmann, J., Seebode, C., Smolorz, S., Schubert, S., & Emmert, S. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2455-7 · Cited by 25
Gambogic Acid Inhibits Melanoma through Regulation of miR‐199a‐3p/ZEB1 Signalling
Liang, L., Zhang, Z., Qin, X., Gao, Y., Zhao, P., Liu, J., & Zeng, W. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13090 · Cited by 25
Self-citationRocha, C. R. R., Garcia, C. C. M., Vieira, D. B., Quinet, A., de Andrade-Lima, L. C., Munford, V., Belizário, J. E., & Menck, C. F. M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.101 · Cited by 25
Prostate Cancer, miRNAs, Metallothioneins and Resistance to Cytostatic Drugs
Pekařík, V., Gumulec, J., Masařík, M., Kizek, R., & Adam, V. (2013) · Current Medicinal Chemistry · doi:10.2174/092986713804910102 · Cited by 24
Yaneff, A., Sahores, A., Gomez, N. V., Carozzo, A., Shayo, C., & Davio, C. A. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171229133259 · Cited by 24
Wang, Z., Liu, G., & Jiang, J. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4690 · Cited by 23
Zhang, Q., Shi, J., Fang, Y., Wang, H., Fu, W., Pan, J., Huang, Y., Yu, J., Yang, J., & Chen, Z. (2016) · International Journal of Cancer · doi:10.1002/ijc.30396 · Cited by 22
Self-citationBenard, A., Janssen, C. M., van den Elsen, P. J., van Eggermond, M. C. J. A., Hoon, D. S. �., van de Velde, C. J. �., & Kuppen, P. J. K. (2014) · APOPTOSIS · doi:10.1007/s10495-014-1042-8 · Cited by 21
Brozović, A., Vukovic, L. D., Polančec, D. S., Arany, I., Köberle, B., Fritz, G., Fiket, Ž., Majhen, D., Ambriović‐Ristov, A., & Osmak, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076397 · Cited by 21
Křížková, S., Fabrik, I., Húska, D., Adam, V., Babula, P., Hraběta, J., Eckschlager, T., Pochop, P., Darsová, D., Kukačka, J., et al. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11124826 · Cited by 20
Erratum: Lysine-specific demethylase KDM3A regulates ovarian cancer stemness and chemoresistance
Ramadoss, S., Sen, S., Ramachandran, I., Roy, S., Chaudhuri, G., & Farias‐Eisner, R. (2017) · Oncogene · doi:10.1038/onc.2017.331 · Cited by 16
Xie, X., He, G., & Siddik, Z. H. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0257-t · Cited by 15
Gao, Z., Yuan, W.-D., Yuan, J.-Q., Yuan, K., & Wang, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.906107 · Cited by 12
Microenvironmental InterFereNce of metabolism regulates chemosensitivity
Akkari, L., & Joyce, J. A. (2016) · Cell Research · doi:10.1038/cr.2016.82 · Cited by 9
Cited by
Linares, J., Sallent-Aragay, A., Badia-Ramentol, J., Recort-Bascuas, A., Méndez, A., Manero-Rupérez, N., Re, D. L., Rivas, E. I., Guiu, M., Zwick, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36334-1 · Cited by 109
Hartmann, J., Henschel, N., Bartmann, K., Dönmez, A., Brockerhoff, G., Koch, K., & Fritsche, E. (2023) · Cells · doi:10.3390/cells12091270 · Cited by 31
AAontology: An Ontology of Amino Acid Scales for Interpretable Machine Learning
Breimann, S., Kamp, F., Steiner, H., & Frishman, D. (2024) · Journal of Molecular Biology · doi:10.1016/j.jmb.2024.168717 · Cited by 15
Regulation of astrocyte metabolism by mitochondrial translocator protein 18 kDa
Firth, W., Robb, J. L., Stewart, D., Pye, K. R., Bamford, R., Oguro‐Ando, A., Beall, C., & Ellacott, K. L. J. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16089 · Cited by 5
Metadata
- Authors
- Zhou, J., Kang, Y., Chen, L., Wang, H., Liu, J., Zeng, S., & Yu, L.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2020-03-20
- Volume
- 11
- Pages
- 343-343
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W3010974323
- Cited by
- 479
- References
- 224
- FWCI
- 21.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.